Photon-Counting CT:
From Pixels to Decisions
Moving beyond higher resolution toward a fundamental shift in quantitative, spectral, and decision-oriented abdominal imaging.
The Physics of Direct Conversion
Visualizing the architectural leap from Energy-Integrating Detectors (EID) to Photon-Counting Detectors (PCD).
Detector Architecture Comparison
Energy Binning & Iodine K-Edge
EID vs. PCCT Architecture
| Feature | Conventional EID | Photon-Counting (PCD) |
|---|---|---|
| Conversion Process | Indirect (Scintillator + Photodiode) | Direct (Semiconductor: CdTe/CZT) |
| Signal Measurement | Integral of total deposited energy | Counting of individual photon pulses |
| Detector Septa | Required (Prevents optical crosstalk) | Not Required (Charge guided by electric field) |
| Electronic Noise | Integrated into the final signal | Eliminated (via low-energy thresholding) |
| Pixel Size (Isocenter) | ~0.50 – 0.625 mm | ~0.15 – 0.20 mm (Ultra-High Resolution) |
| Energy Weighting | High-energy photons over-weighted | All detected photons equally weighted |
Spectral Intelligence Lab
Experience how modifying the Virtual Monoenergetic Image (VMI) keV changes both quantifiable metrics and visible lesion conspicuity.
Clinical Impact
70 keV is the standard baseline for routine portal venous imaging, matching conventional 120 kVp CT datasets.
Performance Profile
Visual Conspicuity Simulator
Watch how lower keV settings push the lesion closer to the Iodine K-edge, making it dramatically brighter.
The Clinical Intelligence Hub
How spectral data at the detector level fundamentally alters patient management.
Hepatic Oncology
Ultra-low keV VMIs amplify iodine signal, revealing occult Colorectal Liver Mets (CRLM) and hypervascular HCC lesions missed on standard 120kVp phases.
Pancreatic PDAC
Unprecedented spatial resolution (0.2mm) eliminates partial volume averaging, which is critical for differentiating arterial abutment from true encasement.
Renal Masses
Iodine Concentration (IC) maps provide an absolute quantitative cutoff (e.g., >0.6 mg/mL) to separate true enhancement from beam-hardening pseudoenhancement.
Comments
Post a Comment